[Treatment of attention deficit hyperactivity disorder in children: results of a multicenter, randomized, double-blind, placebo-controlled clinical trial].
Nikolay N ZavadenkoE V MakushkinD D GaynetdinovaOleg KolokolovE V MalininaE A AntipenkoE Sh SagautdinovaOlga V KhaletskayaA V DmitrievN N MaslovaV V MashinM V PanteleevaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)
The drug Prospekta is an effective and safe treatment for ADHD in patients 7-12 years old.
Keyphrases
- double blind
- placebo controlled
- attention deficit hyperactivity disorder
- clinical trial
- phase iii
- phase ii
- autism spectrum disorder
- end stage renal disease
- study protocol
- open label
- newly diagnosed
- chronic kidney disease
- working memory
- young adults
- emergency department
- randomized controlled trial
- squamous cell carcinoma
- drug induced
- patient reported outcomes